Resources

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Natasha Kirtchuck

February 5, 2026

BrightKaire Featured on i24NEWS: Transforming Depression Treatment with Precision Psychiatry

October 30, 2025

NeuroKaire Enters into R&D Collaboration with Compass Pathways to Pioneer Precision Treatments for Depression

September 30, 2025

NeuroKaire Featured in 360Dx for U.S. Launch of BrightKaire Depression Test

September 10, 2025

NeuroSense's Drug Candidate Shows Early Signals of Benefit in Alzheimer's Patient-Derived Neurons

September 9, 2025

NeuroKaire launches first-of-its-kind clinical test in the US, expected to dramatically reduce the 'trial and error' approach to finding the right antidepressant

Dr. Daphna Laifenfeld on the THERAPY+ Podcast: Rethinking Depression and Neuroplasticity

NeuroKaire Co-Founder on Channel 10: Advancing Personalized Psychiatry

NeuroKaire Awarded Best Pitch by the EIC Scaling Club during HealthTech Investment Days

December 17, 2024

NeuroKaire Secures $10 Million to Advance Precision Medicine for Mental Health

November 20, 2024

NeuroKaire Receives Clinical Laboratory Improvement Amendments Certification

NeuroSense and NeuroKaire (formerly Genetika+) Initiate Precision Medicine Collaboration Beginning with Ongoing Phase 2 Clinical Trial in Alzheimer's Disease

Maria Aguirre Galindo, Reuters Events

September 6, 2023

NeuroKaire (formerly Genetika+): Transforming Digital Health with Precision Medicine Innovations

Carrie Rubinstein, Forbes

Apparently Getting Smarter Makes Us Healthier: AI And Data Analysis Revolutionize Healthcare

Natalie Lisbona

How artificial intelligence is matching drugs to patients

Treatment Approach to Depression Sees Paradigm Shift

February 6, 2023

Clexio and NeuroKaire (formerly Genetika+) Announce Partnership Using Proprietary Antidepressant Screening Platform

Nation World News Desk

January 16, 2023

Science seeks new ways to tackle depression: early detection of risks and personalized treatment

Vittoria D’alessio, Horizon Magazine

December 21, 2022

Defeating depression through early risk detection and targeted medication

December 16, 2022

Extreme Tech Startup Spotlight: Genetika+

Pharma News Intelligence

October 31, 2022

How Brain-in-a-Dish Technology Can Impact the Treatment of MDD

October 19, 2022

NeuroKaire (formerly Genetika+) Announces CE Mark for NeuroKaire™ its AI-powered Tool to Optimize Depression Treatment

Ariel Grossman, NoCamels

September 5, 2022

'Brain-In-A-Dish' Helps Patients Find The Right Antidepressant

US Healthcare Journal

August 15, 2022

KSM Research & Innovation And NeuroKaire (formerly Genetika+) Partner To Seek AI Solutions For Personalization Of Depression Treatment

TheMarker Names NeuroKaire (formerly Genetika+) One of the Top 20 Startups

NeuroKaire (formerly Genetika+) awarded up to €17.5M from European Commission's European Innovation Council (EIC) Accelerator for Europe’s high potential start-ups

Future Medicine

NeuroKaire (formerly Genetika+) Publication Featured in Future Medicine

PMWC International

Dr. Daphna Laifenfeld Speaks at PMWC 2022

ScienceAbroad hosts Dr. Daphna Laifenfeld at Google Campus

NeuroKaire (formerly Genetika+) Wins the BioNJ BioPartnering Company & Pitch Presentation MedTech Award at the BioNJ 12th Annual Bio Partnering Conference

CTO, Nadav Askari, Presents at Biomed Israel

Female Led NeuroKaire (formerly Genetika+) Grew and Gained Funding Through MassChallenge

October 21, 2021

NeuroKaire's (formerly Genetika+) CEO Talia Cohen Solal Brings Precision Medicine to Brain Health

September 30, 2021

NeuroKaire (formerly Genetika+), Pioneer in Personalized Medicine for Psychiatry, Raises $10 Million in an Oversubscribed Series A

Tel Aviv, Israel

Biomed Israel 2025

APA booth

Los Angeles, CA

APA Annual Meeting 2025

Jersey City, NJ

BioNJ BioPartnering Conference 2025

NEI booth

Philadelphia, PA

NEI Spring Congress 2025

November 10, 2024

CNS Summit 2024

Psych

October 29, 2024

Psych Congress 2024

New York City, NY

APA Annual Meeting 2024

Microscopic image of a neuron cell showing its intricate structure, with dendrites extending from the cell body and axon. The cell is part of the nervous system, responsible for transmitting electrical impulses. The nucleus and cytoplasmic details are visible, highlighting the complexity of neural networks.

January 24, 2024

Santa Clara, CA

Microscopic image of a neuron cell showing its intricate structure, with dendrites extending from the cell body and axon. The cell is part of the nervous system, responsible for transmitting electrical impulses. The nucleus and cytoplasmic details are visible, highlighting the complexity of neural networks.

November 8, 2023

CNS Summit 2023

Microscopic image of a neuron cell showing its intricate structure, with dendrites extending from the cell body and axon. The cell is part of the nervous system, responsible for transmitting electrical impulses. The nucleus and cytoplasmic details are visible, highlighting the complexity of neural networks.

September 6, 2023

Nashville, Tennessee

Psych Congress 2023

Microscopic image of a neuron cell showing its intricate structure, with dendrites extending from the cell body and axon. The cell is part of the nervous system, responsible for transmitting electrical impulses. The nucleus and cytoplasmic details are visible, highlighting the complexity of neural networks.

San Francisco, California

APA Annual Meeting 2023

Microscopic image of a neuron cell showing its intricate structure, with dendrites extending from the cell body and axon. The cell is part of the nervous system, responsible for transmitting electrical impulses. The nucleus and cytoplasmic details are visible, highlighting the complexity of neural networks.

Tel Aviv, Israel

Biomed Israel 2023

Microscopic image of a neuron cell showing its intricate structure, with dendrites extending from the cell body and axon. The cell is part of the nervous system, responsible for transmitting electrical impulses. The nucleus and cytoplasmic details are visible, highlighting the complexity of neural networks.

Weizmann Institute of Science (Rehovot, Israel)

Translational neuroscience session hosted by Bina - Bridge Innovate Nurture Advance

Microscopic image of a neuron cell showing its intricate structure, with dendrites extending from the cell body and axon. The cell is part of the nervous system, responsible for transmitting electrical impulses. The nucleus and cytoplasmic details are visible, highlighting the complexity of neural networks.

Barcelona, Spain

Pharma 2023 (Reuters Events)

Microscopic image of a neuron cell showing its intricate structure, with dendrites extending from the cell body and axon. The cell is part of the nervous system, responsible for transmitting electrical impulses. The nucleus and cytoplasmic details are visible, highlighting the complexity of neural networks.

Kfar Blum, Israel

Israeli Society for Biological Psychiatry

Microscopic image of a neuron cell showing its intricate structure, with dendrites extending from the cell body and axon. The cell is part of the nervous system, responsible for transmitting electrical impulses. The nucleus and cytoplasmic details are visible, highlighting the complexity of neural networks.

September 9, 2025

Toward Precision Psychiatry: Innovations and Prospects in Treating Depression

Daphna Laifenfeld, PhD; Claudia Albeldas, MSc; Talia Cohen Solal, PhD; Roger S. McIntyre, MD, FRCPC; Stephen Stahl, MD PhD

December 8, 2024

ACNP 2024: Assessing Synaptic Connectivity as a Biomarker for Drug Response

Talia Cohen Solal, Claudia Albeldas, Liza Rabkina, Moria Ben Yishai, Etay Aloni, Orit Goldman, Daphna Laifenfeld

November 10, 2024

CNS Summit 2024: Neuronal plasticity markers in iPSC-Derived Neurons as a platform for drug response models in Alzheimer’s Disease

Daphna Laifenfeld PhD, David Pattison, Orit Goldman PhD, Shiran Zimri PhD, Nitai Kerem | NeuroKaire, Tel Aviv, Israel | Neurosense Therapeutics, Haifa, Israel

November 10, 2024

CNS Summit 2024: Profiling of Drug Response Mechanisms and Patient Sub-populations Through Readouts From a Biobank of Patient-derived Neurons

Daphna Laifenfeld PhD, Tal Birnberg PhD, David Pattison, Claudia Albeldas, Elena Kagan | NeuroKaire, Tel Aviv, Israel | Clexio Biosciences, Petach Tikvah, Israel

AD/PD 2024 Presentation: Combination Of Ciprofloxacin/Celecoxib As A Novel Therapeutic Approach For Alzheimer’s Disease

Shiran Zimri, Nitai Kerem, Daphna Laifenfeld, David Pattison, Niva Russek-Blum, Diana Shtossel, Vered Sasson, Eidan Loushi, Natalya Yarovinsky, Rafi Hadad, Judith Aharon Peretz, Ferenc Tracik & Rachel Ben-Hayun. NeuroSense Therapeutics, Ltd, Herzliya, Israel | GenetikaPlus, Tel Aviv, Israel | Stroke and Cognition Institute, Rambam Health Care Campus, Haifa, Israel | Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

November 8, 2023

NEI Congress 2023 Presentation: Using patient iPSC-derived neurons to uncover mechanisms associated with response to antidepressant drugs: a framework for precision medicine in depression*

Aleksandra Kugel, PhD, Dana Maimon, MSc, Claudia Albeldas, MSc, Talia Cohen Solal, PhD, Daphna Laifenfeld, PhD

September 6, 2023

Psych Congress 2023 Presentation: Precision Medicine in Depression: Response to Antidepressants is Associated with the Interplay Between Genetic Variants and Gene Expression Levels in Patient-Derived Neurons

Aleksandra Kugel, PhD, Dana Maimon, MSc, Shahar Shohat Koren, PhD, Claudia Albeldas, MSc, Talia Cohen Solal, PhD, Daphna Laifenfeld, PhD

APA 2023 Presentation: Elevated COMT expression in depressed patient derived neurons is associated with a higher response rate to SSRIs and lower response rate to bupropion

Shahar Shohat Koren, PhD, Claudia Albeldas, MSc, Talia Cohen Solal, PhD, Daphna Laifenfeld, PhD

Genetika+: precision medicine solutions for mental health

Claudia Albeldas, Niv Cohen, Sari Natan, Nadav Askari, Daphna Laifenfeld & Talia Cohen Solal

Depression patient-derived cortical neurons reveal potential biomarkers for antidepressant response

Yishai Avior, Shiri Ron, Dana Kroitorou, Claudia Albeldas, Vitaly Lerner, Barbara Corneo, Erez Nitzan, Daphna Laifenfeld & Talia Cohen Solal

Blog

Mental resilience in wartime: how to maintain emotional and psychological stability

Blog

Shai Edery, RN | Clinical Services, NeuroKaire

From Uncertainty to Clarity: Redefining Diagnostic Tools in Mental Health

Blogs

Leah Ezekiel | Noah Horovitz | Austin Adams

Oktoberfest, Beer, and Depression: How Mental Health Affects Taste & Pleasure

Blogs

Dr. Daphna Laifenfeld, CSO of NeuroKaire

Neuroplasticity: A Window Into Brain Health

Blogs

Dr. Talia Cohen Solal, CEO of NeuroKaire

The Mental Health of Olympians: Coping with Pressure and Expectations

Blogs

David Pattison, Head of Business Development

Managing Election Stress: Five Ways to Protect Your Mental Health

Nation World News Desk

A feasibility study aims to predict SSRIs' response in major depression patients using blood-derived biomarkers

Vittoria D’alessio, Horizon Magazine

A study to assess the possibility of using blood-derived biomarkers to predict how well patients with major depression will respond to antidepressents

Therapeutic biomarkers of depression

Induction of microglia-like cells from human monocytes as a tool to study schizophrenia disorder

Vittoria D’alessio, Horizon Magazine

A retrospective study of profiling response to antidepressant drugs

A retrospective study of profiling response to antidepressant drugs - CAN-BIND Integrated biological markers for the prediction of treatment response in depression

BrightKaire Sample Report

BrightKaire One Pager

No Results Found.

We're sorry, but no results matched your search criteria. Please consider modifying your filters or search parameters and try again.